Reduction of Triglycerides in Women on Hormone Replacement Therapy

Completed · Phase 2

Conditions studied: Cardiovascular Diseases, Atherosclerosis, Postmenopause, Heart Diseases

In brief

The purpose of this study is to test the effect of lifestyle intervention on subclinical cardiovascular disease measures in women taking hormone replacement therapy (HRT).

Key facts

Study ID

NCT00023543

Run by

University of Pittsburgh

People needed

508

Starts

2001-09-01

Expected to finish

2010-05-01

Last updated by the study team

2013-06-19

Who can join

Age: 52 and older, up to 60. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• On HRT for at least two years
• Women 52 to 60 years of age
• Three or more years postmenopausal
• Waist circumference greater than 80 cm
• LDLc between 100 and 160 mg/dl
• Body mass index 25-39.9 kg/m2
• Blood Pressure less than 160/95 mm Hg
• Beck Depression Inventory Score less than 20

You may not qualify if…

• Current use of cholesterol-lowering medication
• Diagnosis of diabetes
• On diabetes medication

Where it is running

• University of Pittsburgh — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.